ICD-10 Code D68.31 – Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors (2026): Diagnosis, Symptoms & Billing Guide
2026 ICD-10-CM Diagnosis Code D68.31 – Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
What it is
This code identifies a bleeding disorder caused by an internal circulating anticoagulant, antibody, or inhibitor that interferes with normal clotting. Use it when documentation links the hemorrhagic condition to that specific mechanism.
Clinical signs
Clinical features vary; refer to documentation. Commonly, the record describes unexplained or excessive bleeding with evidence of an acquired coagulation problem, such as an inhibitor affecting clot formation.
When to use this code
Use D68.31 when the provider documents a hemorrhagic disorder due to an intrinsic circulating anticoagulant, antibody, or inhibitor. It fits cases where bleeding is attributed to an acquired inhibitor rather than a congenital clotting defect. If the note only says “coagulopathy” or “bleeding disorder,” check documentation for the exact cause.
Do not use for
Do not use this code for anticoagulant medication effects, inherited clotting disorders, or bleeding with no documented inhibitor cause. If the mechanism is unclear, check documentation.
Coding tip
Code the documented cause of bleeding, and query the provider if the record does not clearly identify an intrinsic circulating anticoagulant, antibody, or inhibitor.